Tags: Pfizer Inc

Pfizer is facing a lawsuit that had been revived 12 years after. The New York-based company is being sued by shareholders of the company, who claimed that they were not informed of the cardiovascular risks of Celebrex and Bextra. The shareholders suffered substantial amount of losses.

The Indian Government has ordered Pfizer India for an immediate ban of a cough syrup, Corex, a prescription drug that have been in the market for more than 30 years.

Pfizer's Wyeth unit has already agreed to pay $784.6 million. This will allegedly settle claims that the company's calculation of the Medicaid rebates for Protonix violated the Federal Civil False Claims Act and other laws.